ARCHIVES

Report: Rising Treatment Costs Due to 340B Discounts

This article is from The Cancer Letter archive.

Vol. 40 No. 20 | May 16, 2014

Download PDF Visit The Full Archive

Related Articles

DCT board Okays Recompetition of Clinical Trials Contracts

October 29, 1993

News Council Says Post Series “Flawed By Sensationalism”

June 11, 1982

Clinical Trials: For ER+ Breast Cancer, Post-Tamoxifen, NSABP Testing Aromasin In Large Trial

June 1, 2001

CIIT’s Swenberg Denies He Is NTP “Industry Representative”

December 12, 1980

FDA Promises No More IND Disruptions Without “Very Valid Reasons,” Nears Agreement With NCI

April 15, 1977

Sustained-Release Leuprolide Under Study In Phase III Trial.

June 30, 2000